Startup Mastery — Lesson 2 of 8
In Lesson 1, Sarah Chen and James Okafor validated their supply chain analytics concept through 47 customer interviews, incorporated NovaTech as a Ltd company, and assigned IP cleanly. They have strong evidence of problem-solution fit and a clear market opportunity.
Now they need capital to build the product. Neither founder can self-fund 12 months of full-time development, cloud infrastructure, and the early commercial hires needed to convert interview conversations into paying customers. They need outside money — but they are too early for institutional venture capital.
This is the pre-seed stage: the first external capital a startup raises, typically from angel investors, friends and family, or early-stage micro-funds. It is the funding round that most founders understand least and negotiate worst.
Pre-seed capital is not just money — it is the round where you set the structural foundations of your cap table, establish your relationship with external shareholders, and create the valuation baseline for every future round. Getting the mechanics wrong here compounds through every subsequent raise.
Pre-seed capital typically comes from three sources, each with different motivations, expectations, and levels of sophistication.
| Source | Typical Cheque | Motivation | Sophistication | Risk to Founder |
|---|---|---|---|---|
| Friends & Family | £5K–£50K | Personal relationship, belief in the founder | Low — often unfamiliar with startup mechanics | High — personal relationships at stake if it fails |
| Angel Investors | £10K–£100K | Financial return, portfolio diversification, mentorship | Medium to high — experienced angels understand risk | Medium — professional relationship with clear terms |
| Micro-VCs / Syndicates | £50K–£250K | Financial return, deal flow for larger funds | High — institutional process, standardised terms | Low — professional, arms-length, well-documented |
NovaTech's approach was deliberate. Sarah and James decided against friends and family capital — not because it was unavailable, but because they wanted investors who could add strategic value beyond the cheque. They sought angels with supply chain or enterprise SaaS experience who could open doors to pilot customers.
Taking money from friends and family is not inherently wrong, but it requires extreme care. If your startup fails — and statistically, it probably will — you need to be certain that the people who invested can absorb the loss without financial hardship or relationship damage. Never accept money from someone who cannot afford to lose it entirely.
An angel investor is a high-net-worth individual who invests personal capital in early-stage companies, typically in exchange for equity or a convertible instrument. In the UK, angels frequently invest through SEIS (Seed Enterprise Investment Scheme) or EIS (Enterprise Investment Scheme), which provide significant tax relief.
SEIS allows angels to invest up to £200,000 per tax year in qualifying companies and claim 50% income tax relief. EIS allows up to £1 million (or £2 million if invested in knowledge-intensive companies) with 30% relief. Both schemes also offer capital gains tax exemption if shares are held for at least three years.
This is why incorporating as a Ltd company matters. SEIS and EIS are only available to qualifying limited companies — not LLPs, not sole traders, not overseas entities. For a UK angel investing £100,000 via SEIS, the effective risk is £50,000 after tax relief. That asymmetry makes early-stage investing significantly more attractive.
At the pre-seed stage, founders and investors often use convertible instruments rather than pricing a formal equity round. This avoids the cost and complexity of a full valuation at a stage where the company has little financial history to value.
The two most common instruments are SAFEs (Simple Agreement for Future Equity) and convertible notes.
A SAFE (Simple Agreement for Future Equity) is an agreement where the investor provides capital now in exchange for the right to receive equity later, when a priced round occurs. It is not debt — there is no interest rate, no maturity date, and no repayment obligation. The investor simply waits until the next equity round and converts at a discount or cap.
Both instruments typically include two key economic terms: a discount rate and a valuation cap.
The discount rate (commonly 15–25%) gives the investor a lower price per share than new investors pay in the next round. If the seed round prices shares at £1.00 and the SAFE has a 20% discount, the SAFE holder converts at £0.80 per share.
The valuation cap sets a maximum valuation at which the SAFE converts, regardless of how high the next round prices the company. This protects the angel's upside — if the company grows rapidly before the next round, the angel still converts at the capped valuation rather than the higher actual valuation.
In most SAFEs, the investor receives whichever is more favourable: the discount or the cap. They do not stack. If the cap produces a lower price per share than the discount, the cap applies. This is a common source of confusion for first-time founders.
Sarah and James raised £150,000 from two angel investors — Margaret Liu (a former VP of Supply Chain at a major automotive manufacturer) and David Reeves (an angel who had previously backed three enterprise SaaS companies). Both invested via SAFEs.
| Term | Value |
|---|---|
| Total raised | £150,000 |
| Instrument | SAFE (post-money) |
| Valuation cap | £3,000,000 |
| Discount rate | 20% |
| Number of investors | 2 (£75,000 each) |
With a post-money SAFE at a £3M cap, the investors' ownership is calculated immediately:
Angel ownership = Investment / Valuation Cap
£150,000 / £3,000,000 = 5.0% (combined)
Margaret and David each own 2.5% on a post-money basis. Sarah and James retain 95% between them (52.25% and 42.75% respectively, reflecting their 55/45 split).
This is the concept that trips up more first-time founders than any other. The difference between pre-money and post-money valuation determines how much of your company you are actually selling.
Pre-money valuation is the agreed value of the company before the investment is added. Post-money valuation is the pre-money valuation plus the investment amount. The investor's ownership percentage is calculated as: Investment / Post-Money Valuation.
Here is the arithmetic, using NovaTech's numbers in a hypothetical priced round scenario:
| Component | Calculation | Value |
|---|---|---|
| Pre-money valuation | Agreed between founders and investors | £750,000 |
| Investment amount | Capital being invested | £150,000 |
| Post-money valuation | Pre-money + Investment | £900,000 |
| Investor ownership | Investment / Post-money | 16.7% |
| Founder ownership | 1 - Investor ownership | 83.3% |
If Sarah and James had agreed to a £750,000 pre-money valuation with a £150,000 investment, the investors would own 16.7% of the company (£150K / £900K). The founders would retain 83.3%.
Now watch what happens if the founders confuse pre-money and post-money. If they agree to a "£750,000 valuation" without specifying pre-money or post-money, the investor might reasonably argue it is a post-money valuation — meaning the investor gets £150K / £750K = 20.0% instead of 16.7%. That 3.3 percentage point difference compounds through every future round.
Always specify whether a valuation is pre-money or post-money. "We are raising at a £3M valuation" is ambiguous. "We are raising £150K on a £3M post-money SAFE cap" is precise. Ambiguity in term sheets costs founders equity.
NovaTech's SAFE has a £3M valuation cap. This means that when the next priced round occurs, the SAFE investors convert their investment into equity at whichever produces a lower price per share: the 20% discount to the round price, or the £3M cap.
Here is how this plays out in practice. Suppose NovaTech's seed round is priced at a £6M pre-money valuation:
| Conversion Method | Calculation | Price Per Share | Shares Received (per £75K) |
|---|---|---|---|
| At round price | £6M / 10M shares = £0.60 | £0.60 | 125,000 |
| With 20% discount | £0.60 x 0.80 = £0.48 | £0.48 | 156,250 |
| At £3M cap | £3M / 10M shares = £0.30 | £0.30 | 250,000 |
| SAFE converts at | Lower of discount or cap | £0.30 | 250,000 |
The cap produces a much lower price per share (£0.30 vs £0.48), so the SAFE converts at the cap. Each angel receives 250,000 shares at £0.30 instead of 156,250 shares at £0.48 — effectively giving them 5% of the company on a pre-seed valuation of £3M, even though the seed round values NovaTech at £6M.
This is the angel's reward for investing early when the risk was highest. The cap ensures their upside is protected if the company appreciates significantly between the pre-seed and the seed round.
In practice, the valuation cap almost always dominates the discount rate. If your startup is growing — which is the entire point — the next round's valuation will be substantially higher than the cap. A 20% discount on a £6M valuation gives a better price than the round price, but the £3M cap gives a better price still. This is why experienced angels negotiate hard on the cap and barely discuss the discount.
Use the Opagio Intangible Asset Calculator to model how different cap levels affect your dilution at each funding stage.
At the pre-seed stage, you are pitching to angels, not venture capitalists. Understanding what each type of investor prioritises will save you from crafting the wrong pitch.
| Criterion | Angel Investors | Venture Capitalists |
|---|---|---|
| Team | Primary factor — investing in people they believe in | Important, but balanced against market and traction |
| Market size | Must be credible, but angels accept smaller markets | Must be venture-scale (£1B+ TAM typically required) |
| Traction | Problem-solution fit is sufficient; revenue not required | Expect product-market fit evidence, ideally early revenue |
| Product | Prototype or MVP is helpful but not essential | Working product with user data expected |
| Financial model | Nice to have; angels know early models are fiction | Expected, with clear unit economics and path to scale |
| Valuation | Flexible; SEIS/EIS relief reduces price sensitivity | Disciplined; must fit portfolio return model |
| Due diligence | Lighter — references, market check, IP review | Rigorous — legal, financial, technical, commercial |
| Board seat | Rarely requested | Typically required at Series A and beyond |
Margaret Liu invested in NovaTech primarily because of Sarah's supply chain expertise and the strength of the customer interview data. David Reeves invested because he had seen the enterprise SaaS playbook work three times before and believed James's technical background was strong enough to execute. Neither angel asked for a board seat or detailed financial projections — they asked for evidence of a real problem and a credible team.
Margaret's due diligence consisted of three calls with supply chain directors from Sarah's interview list, a review of James's published research, and a meeting with both founders. Total time from first meeting to signed SAFE: 6 weeks. Compare this to a typical Series A VC process: 3–6 months of diligence, multiple partner meetings, and detailed legal negotiation.
Your pitch deck at pre-seed is not a business plan — it is a structured story that answers five questions in 12 slides or fewer.
Describe the pain point with specificity. Use data from customer interviews. NovaTech's deck led with the £1.8M median cost per supply disruption and the 87% incidence rate.
Explain your approach at a level your audience can understand. Show the product vision, even if you only have mockups. NovaTech showed a dashboard wireframe with a sample disruption prediction.
Market timing and market sizing. NovaTech cited post-COVID supply chain fragility and the £8.2B TAM / £1.2B SAM / £24M SOM framework from their analysis.
Founder backgrounds and why they are uniquely positioned. Sarah's 8 years in supply chain operations. James's ML research at Imperial. Their combined insight into the problem and solution.
The ask: how much capital, what instrument, what you will do with it, and what milestones it will fund. NovaTech asked for £150K via SAFE to build an MVP and secure 3 pilot customers within 12 months.
Dilution is not something that happens to you — it is a trade you make. You trade a percentage of ownership for capital that increases the total value of the company. If the trade is good, your smaller percentage is worth more in absolute terms.
Here is NovaTech's cap table evolution from founding through pre-seed:
| Shareholder | At Founding | Post Pre-Seed (SAFE) | Post Seed (Projected) |
|---|---|---|---|
| Sarah Chen (CEO) | 55.0% | 52.25% | ~41.8% |
| James Okafor (CTO) | 45.0% | 42.75% | ~34.2% |
| Angel investors (SAFE) | — | 5.0% | ~5.0% |
| Seed investors | — | — | ~15.0% |
| Employee option pool | — | — | ~4.0% |
| Total | 100% | 100% | 100% |
Sarah's stake drops from 55% to a projected 41.8% after the seed round. But if the seed round values NovaTech at £6M post-money, her 41.8% is worth £2.51M — compared to 55% of a company worth essentially nothing at founding. Dilution is only a problem if the value per share is not increasing faster than your percentage is decreasing.
Understanding how intangible assets drive startup valuations is critical at this stage. The intangible assets NovaTech is building — its technology capital, early customer relationships, and founder human capital — are what justify the step-up from a £3M SAFE cap to a £6M seed valuation. Investors are not paying for revenue at pre-seed; they are paying for the intangible asset base you have accumulated.
Every funding round dilutes founders. The question is not "how do I avoid dilution?" but "am I getting enough value — capital, expertise, connections, credibility — to justify the equity I am giving up?" NovaTech traded 5% for £150K, two strategic angels, and the runway to build an MVP. That is a trade worth making.
In Lesson 3, NovaTech builds its MVP, signs its first paying customers, and prepares for a seed round with institutional venture capital. We will cover product-market fit metrics, unit economics, and the valuation methods VCs actually use — including how intangible asset measurement gives founders an edge in pricing negotiations.
This article is part of the Startup Mastery series — 8 lessons following NovaTech from idea to exit. Written by Ivan Gowan, CEO of Opagio.
Ivan Gowan is CEO of Opagio, the growth platform that helps startups and investors measure, manage, and grow intangible assets. Before founding Opagio, Ivan held senior technology and leadership roles across financial services and digital platforms. Meet the team.
Most startups fail not because the idea was bad, but because the founders never validated it. This lesson follows NovaTech's co-founders from a chance meeting at a supply chain conference to a validated business concept — covering market sizing, co-founder dynamics, IP assignment, and the three risks every investor evaluates.
Read more →Get the latest insights on intangible asset growth and productivity delivered to your inbox.
Book a free consultation to see how the Opagio Growth Platform can help your business.